First impressions of the use of meptazinol in general practice.
Meptazinol which is a potent opiate antagonist analgesic has been assessed by the oral route at a dose of 200 mg 3-6 hourly. The analgesic profile shows a significant fall in pain score by 2 hours which was the earliest recording time. Satisfactory pain relief was maintained during 3 days of treatment. The side-effect profile was of a low order and there was no adverse effect on haematological and biochemical screens.
D000293:Adolescent; D000328:Adult; D000368:Aged; D001381:Azepines / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D005260:Female; D006801:Humans; D008297:Male; D008621:Meptazinol / Q000009:adverse effects / Q000627:therapeutic use*; D008875:Middle Aged; D010146:Pain / Q000175:diagnosis / Q000188:drug therapy*
D001381:Azepines; D008621:Meptazinol